T-cell tolerance to inhaled allergens: mechanisms and therapeutic approaches

Expert Opin Biol Ther. 2008 Jun;8(6):769-77. doi: 10.1517/14712598.8.6.769.

Abstract

Background: Specific immune response to allergens is decisive in the development of clinically healthy or allergic states.

Objective: Recent developments in the mechanisms of allergen-specific peripheral tolerance can be used for future treatment modalities.

Methods: This review focuses on recent developments in allergen tolerance.

Results/conclusion: The balance between allergen-specific IL-10-secreting T regulatory cells (Tr1) and T helper 2 (Th2) cells appears to be decisive in the development of allergic and healthy immune response against allergens. Induction of IL-10- and TGF-beta-producing Tr1 cells, IgG4-isotype-blocking antibodies, and suppressed mast cells, basophils and eosinophils represent major components of a relatively normalized immune response after allergen-specific immunotherapy and healthy immune response to aeroallergens in sensitized individuals.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Allergens / immunology*
  • Basophils / immunology
  • Desensitization, Immunologic / methods
  • Dose-Response Relationship, Immunologic
  • Eosinophils / immunology
  • Histamine Release
  • Humans
  • Immune Tolerance* / physiology
  • Immunoglobulin G / biosynthesis
  • Immunologic Factors / therapeutic use
  • Immunosuppression Therapy / methods*
  • Inhalation Exposure*
  • Interleukin-10 / metabolism
  • Mast Cells / immunology
  • Respiratory Hypersensitivity / immunology*
  • Respiratory Hypersensitivity / therapy
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocyte Subsets / immunology*
  • Transforming Growth Factor beta / metabolism

Substances

  • Allergens
  • IL10 protein, human
  • Immunoglobulin G
  • Immunologic Factors
  • Transforming Growth Factor beta
  • Interleukin-10